PODESTA GROUP, INC. for COVIDIEN
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Pub. L. 112-29, Leahy-Smith America Invents Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARANTHAN JONES | — |
| THOMAS B SPARKMAN | — |
Health Issues HCR
Patient Protection and Affordable Care Act implementation. S. 99, American Medical Isotopes Production Act of 2011; issues related to nuclear medicine. FDA approval process/510(k). Medical device tax. H.R. 3209, Premarket Predictability Act. H.R. 3203 / S. 1943, Novel Device Regulatory Relief Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3205, FDA Renewing Efficiency from Outside Review Management Act. H.R. 3211, Humanitarian Device Reform Act. H.R. 3208, Patients Come First Act. H.R. 3206, Cultivating Scientific Experts to Foster Innovation Act. H.R. 3214, Food and Drug Administration Mission Reform Act. H.R. 3207, Modernizing Laboratory Test Standards for Patients Act. H.R. 3204, Guidance Accountability and Transparency Act. S. 1700, The Medical Device Regulatory Improvement Act. S. 1865, The Patient Access to Medical Innovation Act. S. 1972, A bill to amend the Food and Drug Administrations mission. S. 1995, A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN | — |
| ARANTHAN JONES | — |
| STEPHEN NORTHRUP | — |
| THOMAS B SPARKMAN | — |
Taxation/Internal Revenue Code TAX
International taxation on direct foreign investment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRISTINA ANTELO New | — |
| DANIELE BAIERLEIN | — |
| ARANTHAN JONES | — |
Budget/Appropriations BUD
H.R. 2055, Consolidated Appropriations Act, 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARANTHAN JONES | — |
Pharmacy PHA
Issues involving controlled substances and pain and addiction drugs. Issues related to acetaminophen.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN | — |
| ARANTHAN JONES | — |
| STEPHEN NORTHRUP | — |
| ANTHONY PODESTA | — |
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.